Feb. 16, 2017 (GLOBE NEWSWIRE) — Novastep, Inc., and its affiliates (“Novastep” or the “Company”), a global medical technologies company specializing in the foot and ankle, has announced a national vendor contract with United Surgical Partners International (USPI).
“This agreement allows USPI facilities access to our foot and ankle portfolio and cleanSTART® deployment technology,” said Travis Johnson, Vice President, National Accounts of Novastep, Inc. “Novastep’s product line focuses on meeting the needs of not only the hospital and outpatient surgery center market, but likewise delivering high quality products to meet the needs of the patient”.
“Our customers recognize that Novastep has the quality and breadth in their product line that is needed in today’s healthcare environment,” said Jon Pruitt, Vice President of USPI’s contracting services department.” We are extremely excited about this new agreement and the value it will bring to our customers.”
Operating room efficiency and cost reduction are prime areas of focus for Novastep. The company works directly with hospitals and surgical centers to streamline healthcare costs and process flows. The cleanSTART deployment technology provides a systematized, customizable logistics platform that substantially reduces inventory and sterile field volumes, while minimizing lost or damaged instrument delays and lifecycle costs. This deployment technology permits multiple, simultaneous OR placements and back-up instruments are immediately available.
About United Surgical Partners International
USPI is the largest provider of ambulatory surgery in the United States, serving more than 9,000 physicians and partnering with over 50 not-for-profit health systems nationwide to deliver top tier care to their patients and to help grow their capabilities in the markets they serve. The company currently has ownership interests in or operates 269 ambulatory surgery facilities.
Novastep is a global medical device company specializing in the design, development and commercialization of advanced technologies that treat conditions affecting the foot and ankle. The Company is focused on optimizing clinical efficiencies, inventory management and healthcare economics by transforming the way foot and ankle products are deployed and utilized in the surgical environment. Novastep has allied itself with a strategic network of key international opinion leaders to deliver breakthrough technologies, innovative services and compelling medical education programs to the foot and ankle community. Novastep’s portfolio, services and distribution platforms are uniquely positioned to address foot and ankle trauma, deformity corrections and Charcot fracture management.
For further information concerning this announcement and/or Novastep, Inc., send all inquiries to firstname.lastname@example.org or call 877.287.0795.
For general information: novastep-us.com